Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrotic Interstitial Lungs Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02596841
What this trial is testing

Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias

Who this might be right for
Usual Interstitial PneumoniaNonspecific Interstitial Pneumonia
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 60
Not applicableLooking for participantsNCT06751069
What this trial is testing

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

Who this might be right for
Lung FibrosisLung Interstitial Disease
Mayo Clinic 460
Not applicableStudy completedNCT05130034
What this trial is testing

Home-based Pulmonary Rehabilitation and Health Coaching in Fibrotic Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lung Disease
Mayo Clinic 81
Not applicableStudy completedNCT01781793
What this trial is testing

Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung Disease

Who this might be right for
Lung; Disease, Interstitial, With Fibrosis
University of British Columbia 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06329401
What this trial is testing

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis Secondary to Systemic Sclerosis+7 more
Avalyn Pharma Inc. 375
Not applicableStudy completedNCT06016959
What this trial is testing

Specialist Dietetic Intervention in Malnourished Patients with Fibrotic ILD: a Randomised Controlled Pilot Trial

Who this might be right for
Interstitial Lung Disease
Royal Brompton & Harefield NHS Foundation Trust 40
Not applicableStudy completedNCT03300583
What this trial is testing

Toward Self-management in ILD

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisConnective Tissue Related ILD+2 more
Kingston University 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07210008
What this trial is testing

"Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis"

Who this might be right for
Hypersensitivity Pneumonitis
Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)Looking for participantsNCT06189820
What this trial is testing

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

Who this might be right for
Pulmonary FibrosisLung FibrosisIdiopathic Pulmonary Fibrosis+1 more
Erasme University Hospital 70
Testing effectiveness (Phase 2)Looking for participantsNCT06714123
What this trial is testing

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Who this might be right for
Pulmonary Fibrosis, Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Vejle Hospital 140
Not applicableStudy completedNCT03800914
What this trial is testing

High Intensity Interval Training in Fibrotic Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lung Disease
Monash University 131
Large-scale testing (Phase 3)Looking for participantsNCT07613099
What this trial is testing

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

Who this might be right for
Allogeneic Stem Cell TransplantationLung Allograft TransplantationInterstitial Lung Disease+3 more
National Heart, Lung, and Blood Institute (NHLBI) 210
Not applicableNot Yet RecruitingNCT07786090
What this trial is testing

Mechanistic 129 Xe MRI Study to Assess Therapeutic Response in Fibrotic Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lung Disease
Dr. Grace Parraga 35
Not applicableStudy completedNCT06465654
What this trial is testing

Automated Oxygen Titration During Walking in Patients With Lung Fibrosis (OXYWILD)

Who this might be right for
Fibrosis LungRespiratory Therapy
Janne Hastrup Jensen 29
Not applicableLooking for participantsNCT07466420
What this trial is testing

Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.

Who this might be right for
Fibrotic Interstitial Lungs DiseasesIdiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis
Katerina M. Antoniou 100
Large-scale testing (Phase 3)Enrolling By InvitationNCT04905693
What this trial is testing

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseProgressive Pulmonary Fibrosis
United Therapeutics 1,850
Not applicableStudy completedNCT04586946
What this trial is testing

FIBRotic Interstitial Lung Disease and Nocturnal OXygen

Who this might be right for
Idiopathic Pulmonary FibrosisObstructive Sleep ApneaSleep Disturbance+1 more
Guy's and St Thomas' NHS Foundation Trust 102
Not applicableStudy completedNCT05957198
What this trial is testing

Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 114,921
Post-approval studies (Phase 4)UnknownNCT03260556
What this trial is testing

Pirfenidone for Progressive Fibrotic Sarcoidosis

Who this might be right for
Sarcoidosis, Pulmonary
University of Cincinnati 60
Not applicableLooking for participantsNCT07482917
What this trial is testing

Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial

Who this might be right for
Interstitial Lung Disease (ILD)Suspected Interstitial Lung DiseaseFibrotic Interstitial Lung Disease+2 more
Hospital de Granollers 92
Next Page